Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
(NASDAQ:MAZE) SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precisio...